Related Experiment Videos
Sufentanil citrate: a new opioid analgesic for use in anesthesia
Abstract:
Sufentanil citrate is a potent analogue of fentanyl that has been evaluated primarily for use in opioid anesthesia. It is a pure mu receptor agonist and produces the typical spectrum of opioid effects. The major side effects are truncal rigidity and prolonged respiratory depression. In doses of 4-30 micrograms/kg sufentanil produces hypnosis and suppresses most hemodynamic and hormonal responses to surgery without producing significant cardiovascular depression. In this respect sufentanil and fentanyl have clear advantages over morphine, meperidine and potent inhalation anesthetics. Compared to fentanyl, sufentanil has a more rapid onset and shorter duration of action. The relatively high concentration of commercially available sufentanil injection will make it much more convenient for its intended application than fentanyl injection. This new agent will be used primarily for open-heart surgery and major operations in patients with severe cardiovascular compromise.
Insights
Sufentanil citrate, a potent mu receptor agonist, offers rapid hypnosis and suppresses surgical stress responses with minimal cardiovascular impact. It provides advantages over other opioids and anesthetics, particularly for high-risk surgeries.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Sufentanil citrate is a potent synthetic opioid, structurally related to fentanyl.
- It acts as a pure mu receptor agonist, eliciting typical opioid effects.
Purpose of the Study:
- To evaluate sufentanil citrate for its efficacy and safety in opioid anesthesia.
- To compare its pharmacokinetic and pharmacodynamic profile against fentanyl and other analgesics.
Main Methods:
- Clinical evaluation of sufentanil citrate in surgical anesthesia.
- Dose-ranging studies (4-30 micrograms/kg) to assess hypnotic and hemodynamic effects.
- Comparative analysis with fentanyl, morphine, and meperidine.
Main Results:
- Sufentanil citrate induces hypnosis and blunts hemodynamic and hormonal responses to surgery effectively.
- It demonstrates minimal cardiovascular depression, superior to morphine and meperidine.
- Compared to fentanyl, sufentanil exhibits a faster onset and shorter duration of action.
- Major side effects include truncal rigidity and prolonged respiratory depression.
Conclusions:
- Sufentanil citrate is a valuable agent for opioid anesthesia, especially in cardiovascularly compromised patients undergoing major surgery.
- Its rapid onset, potent effects, and favorable hemodynamic profile offer distinct advantages.
- High concentration formulations enhance convenience for surgical applications.